Progress toward an Epstein-Barr virus vaccine
Introduction Epstein-Barr virus (EBV), or Human gammaherpesvirus 4, infects over 90% of adults globally. While often asymptomatic in children, EBV causes infectious mononucleosis in adolescents and establishes lifelong latency in B lymphocytes. A 2022 landmark study of 10 million U.S. military perso...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis Group
2026-12-01
|
| Seria: | Expert Review of Vaccines |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.tandfonline.com/doi/10.1080/14760584.2026.2686294 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|